Clinical Trials · NCT01166958
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Wisconsin, Madison
- Enrollment
- 26
- Start date
- Sep 2010
- Locations
- 1 site, United States
- Primary endpoint
- Serum Markers of Skeletal Turnover (Serum CTX)